January 2007
Davis's Drug Guide for Nurses, 10th edition;2007, p616
The article presents a nursing guide for several oral hypoglycemic agents, including glimepiride, glipizide, and glyburide, drugs used for controlling blood glucose in patients with non-insulin-dependent diabetes mellitus. The mechanism of action of the drug is discussed. Information on its pharmacokinetics is provided. Precautionary measures and contraindications for its use are cited. Adverse effects a patient who is taking the drug may manifest are also mentioned. Nursing assessment and interventions are discussed.


Related Articles

  • miglitol.  // Davis's Drug Guide for Nurses, 10th edition;2007, p798 

    The article presents a nursing guide for miglitol, a drug used for management of non-insulin-dependent diabetes mellitus. The mechanism of action of the antidiabetic agent is discussed. Information on its pharmacokinetics is provided. Precautionary measures and contraindications for its use are...

  • The Pharmacogenetics of Type 2 Diabetes: A Systematic Review. Maruthur, Nisa M.; Gribble, Matthew O.; Bennett, Wendy L.; Bolen, Shari; Wilson, Lisa M.; Balakrishnan, Poojitha; Sahu, Anita; Bass, Eric; Kao, W. H. Linda; Clark, Jeanne M. // Diabetes Care;Mar2013, Vol. 37 Issue 3, p876 

    OBJECTIVE We performed a systematic review to identify which genetic variants predict response to diabetes medications. RESEARCH DESIGN AND METHODS We performed a search of electronic databases (PubMed, EMBASE, and Cochrane Database) and a manual search to identify original, longitudinal studies...

  • Efficacy and Safety of Lixisenatide Once-Daily Morning or Evening Injections in Type 2 Diabetes Inadequately Controlled on Metformin (GetGoal-M). AHRÉN, BO; LEGUIZAMO DIMAS, ANICETO; MIOSSEC, PATRICK; SAUBADU, STÉPHANE; ARONSON, RONNIE // Diabetes Care;Sep2013, Vol. 36 Issue 9, p2543 

    OBJECTIVE--To examine the efficacy and safety of lixisenatide (20 µg once daily, administered before the morning or evening meal) as add-on therapy in patients with type 2 diabetes insufficiently controlled with metformin alone. RESEARCH DESIGN AND METHODS--This was a 24-week, randomized,...

  • Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus. Kolterman, Orville G.; Kim, Dennis D.; Shen, Larry; Ruggles, James A.; Nielsen, Loretta L.; Fineman, Mark S.; Baron, Alain D. // American Journal of Health-System Pharmacy;1/15/2005, Vol. 62 Issue 2, p173. 

    Purpose. The pharmacology and tolerability of exenatide in patients with type 2 diabetes mellitus were studied. Methods. Two randomized, single-blind, placebo-controlled studies were conducted. Treatment with oral antidiabetic agents was stopped 14 days before study initiation. In the first...

  • Changing the Treatment Paradigm for Type 2 Diabetes. Del Prato, Stefano; Penno, Giuseppe; Miccoli, Roberto // Diabetes Care;Nov2009 Supplement, Vol. 32, pS217 

    The authors cite the hindrances in type 2 diabetes treatment to demonstrate the need for change. Based on studies, they say that long-term adherence to diet and exercise is needed to ensure their effectiveness in glycemic control. They add that no hypoglycemic agent is available that can...

  • Pharmacokinetics, efficacy and safety of aleglitazar for the treatment of type 2 diabetes with high cardiovascular risk.  // Current Medical Literature: Diabetes;2011, Vol. 28 Issue 4, p136 

    The article comments on a study regarding the pharmocokinetics, efficacy and safety of the anti-diabetic drug aleglitazar for treating type 2 diabetes patients with concomitantly high cardiovascular risk in terms of improvements such as in glycemia, triglycerides and blood pressure.

  • Insulin Management of Type 2 Diabetes Mellitus. PETZNICK, ALLISON // American Family Physician;7/15/2011, Vol. 84 Issue 2, p183 

    Insulin therapy is recommended for patients with type 2 diabetes mellitus and an initial A1C level greater than 9 percent, or if diabetes is uncontrolled despite optimal oral glycemic therapy. Insulin therapy may be initiated as augmentation, starting at 0.3 unit per kg, or as replacement,...

  • What About Diabetes Drugs?  // Prevention;May2012, Vol. 64 Issue 5, p38 

    The article offers information on drugs indicated for treating type 2 diabetes. Metformin is the most common drug prescribed to diabetics. Gastric upset is the usual side effect associated with the drug. Victoza, a new diabetes drug, is a noninsulin medication that can be taken daily....

  • ADVERSE EFFECTS OF METFORMIN IN COMBINATION WITH GLIMEPIRIDE AND GLIBENCLAMIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. Pravinkumar, V. Ingle; Gokul, S. Talele // Asian Journal of Pharmaceutical & Clinical Research;Jan-Mar2012 Supplement, p108 

    In type 2 diabetes mellitus, it is considered that the lowered insulin secretion and the lowered insulin sensitivity cause hyperglycaemia. Sulfonylureas have strong blood-glucose lowering effect by stimulating insulin secretion and have been widely used in the treatment of type 2 diabetes....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics